Our results on the functional activation and ubiquitination of TRPM8 may support a strategy for targeting the androgen-TRPM8-AR interaction or rescuing PMTRPM8 expression as a new therapeutic application to treat PC patients in the future (Figure 5C). Here, AR is linked to pachyonychia congenita.